Polymorphisms in the TNF-α and TNF-receptor genes in patients with coronary artery disease

被引:70
作者
Allen, RA
Lee, EM
Roberts, DH
Park, BK
Pirmohamed, M
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
[2] Blackpool Victoria Hosp, Blackpool, England
关键词
atherosclerosis; coronary artery disease; genetics; TNF-alpha;
D O I
10.1046/j.1365-2362.2001.00907.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Coronary artery disease (CAD) is both multifactorial and polygenic in nature. Atheroma formation, the pathological hallmark of CAD, is an inflammatory process, with pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), having a major role in its pathogenesis. We have therefore investigated whether polymorphisms in the TNF-alpha (- 238 and - 308), TNF receptor 1 (position - 609 and + 10, intron 6) and TNF receptor 2 (position + 422, codon 198) genes show an association with CAD. Materials and methods Patients with angiographically proven single vessel (n = 58) and multivessel (n = 122) CAD were compared to patients with angiographically proven normal coronary arteries (n = 79) and volunteers without clinical evidence of CAD (n = 250). Genotyping was performed by PCR-RFLP analysis. For the TNF-alpha polymorphisms, a meta-analysis of all published studies was also undertaken. Results No significant differences in allele or genotype frequencies were found between the normal coronary artery group or healthy volunteers and patients with CAD for any of the polymorphisms. There was also no difference in allele frequency between patients with single- and multivessel disease. For the - 308 and - 238 TNR alpha gene polymorphisms, a meta-analysis of our data and previously published studies failed to demonstrate any significant association with CAD. Conclusions Polymorphisms in the TNF-alpha promoter region and TNF-receptor genes are not associated with the development of CAD.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 46 条
  • [1] Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus
    Al-Ansari, AS
    Ollier, WER
    Villarreal, J
    Ordi, J
    Teh, LS
    Hajeer, AH
    [J]. TISSUE ANTIGENS, 2000, 55 (01): : 97 - 99
  • [2] Arias AI, 1997, EXP CLIN IMMUNOGENET, V14, P118
  • [3] DETECTION AND LOCALIZATION OF TUMOR NECROSIS FACTOR IN HUMAN ATHEROMA
    BARATH, P
    FISHBEIN, MC
    CAO, J
    BERENSON, J
    HELFANT, RH
    FORRESTER, JS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (05) : 297 - 302
  • [4] Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
    Bouma, G
    Crusius, JBA
    Pool, MO
    Kolkman, JJ
    VonBlomberg, BME
    Kostense, PJ
    Giphart, MJ
    Schreuder, GMT
    Meuwissen, SGM
    Pena, AS
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) : 456 - 463
  • [5] BRAUN N, 1996, NEUROSCI LETT, V215, P74
  • [6] BRINKMAN BMN, 1995, HUM GENET, V96, P493
  • [7] POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS
    CABRERA, M
    SHAW, MA
    SHARPLES, C
    WILLIAMS, H
    CASTES, M
    CONVIT, J
    BLACKWELL, JM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) : 1259 - 1264
  • [8] CAMBIEN F, 1997, MOL MED TODAY MAY, P197
  • [9] Safety and efficacy of a soluble P75 tumor necrosis factor receptor (enbrel, etanercept) in patients with advanced heart failure
    Deswal, A
    Bozkurt, B
    Seta, Y
    Parilti-Eiswirth, S
    Hayes, FA
    Blosch, C
    Mann, DL
    [J]. CIRCULATION, 1999, 99 (25) : 3224 - 3226
  • [10] Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
    Francis, SE
    Camp, NJ
    Dewberry, RM
    Gunn, J
    Syrris, P
    Carter, ND
    Jeffery, S
    Kaski, JC
    Cumberland, DC
    Duff, GW
    Crossman, DC
    [J]. CIRCULATION, 1999, 99 (07) : 861 - 866